ÂÜÀòÂÒÂ×

Nick Roelofs is a seasoned professional in the healthcare and life sciences sectors, currently serving as a Board Member at Seer and Velsera, and as Thematic Partner at Summa Equity. With extensive experience as Chairman of the Board at Sengenics and Chairperson of the Board at One BioMed Pte Ltd, Roelofs also holds advisory roles at Nordic Capital, LGC, and 908 Devices. Previously, Roelofs was Board Member at Olink Proteomics and is currently the Chief Executive Officer of Life Science Telemetry, specializing in healthcare consulting. Roelofs completed a Ph.D. in Chemistry at the University of Nevada, Reno and holds a Master's degree in Organic Chemistry from Iowa State University.